ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c

November 5, 2009 9:06 AM EST

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) reports Q3 loss of $0.21, versus the analyst estimate of ($0.18). Revenue for the quarter was $2.16 billion, which compares to the estimate of $2.59 billion.


Related Categories

Earnings

Stocks Mentioned

ARIA 2.16

-0.03 -1.37%
Volume: 1,199,799
Track ARIA


Add Your Comment